In support of this, Yuki et al. (145) had previously reported IFN-β to reduce proliferation, self-renewal capacity, and tumorigenesis in human glioma-initiating cells (GICs) by inducing their terminal differentiation into oligodendrocytes via STAT3 activation. The gene discussed is IFNB1; the disease is central nervous system cancer.